Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-025889
Filing Date
2012-04-26
Accepted
2012-04-26 18:23:18
Documents
1
Period of Report
2012-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd343163.html 4  
1 FORM 4 rrd343163.xml 4 6203
  Complete submission text file 0001181431-12-025889.txt   7621
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3204 BEVERLY DRIVE DALLAS TX 75205
Business Address
MAULDIN JOHN F (Reporting) CIK: 0001522480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 12784984